197 related articles for article (PubMed ID: 3392207)
1. Effect of beta-hydroxybutyrate on whole-body leucine kinetics and fractional mixed skeletal muscle protein synthesis in humans.
Nair KS; Welle SL; Halliday D; Campbell RG
J Clin Invest; 1988 Jul; 82(1):198-205. PubMed ID: 3392207
[TBL] [Abstract][Full Text] [Related]
2. Effect of ketone bodies on glucose production and utilization in the miniature pig.
Müller MJ; Paschen U; Seitz HJ
J Clin Invest; 1984 Jul; 74(1):249-61. PubMed ID: 6376544
[TBL] [Abstract][Full Text] [Related]
3. Inability to stimulate skeletal muscle or whole body protein synthesis in type 1 (insulin-dependent) diabetic patients by insulin-plus-glucose during amino acid infusion: studies of incorporation and turnover of tracer L-[1-13C]leucine.
Bennet WM; Connacher AA; Smith K; Jung RT; Rennie MJ
Diabetologia; 1990 Jan; 33(1):43-51. PubMed ID: 2406180
[TBL] [Abstract][Full Text] [Related]
4. Effects of D-beta-hydroxybutyrate and long- and medium-chain triglycerides on leucine metabolism in humans.
Beaufrère B; Chassard D; Broussolle C; Riou JP; Beylot M
Am J Physiol; 1992 Mar; 262(3 Pt 1):E268-74. PubMed ID: 1312786
[TBL] [Abstract][Full Text] [Related]
5. Effect of DL-3-hydroxybutyrate infusions on leucine and glucose kinetics in burned rats receiving TPN.
Maiz A; Moldawer LL; Bistrian BR; Yamazaki K; Mok KT; Blackburn GL
J Nutr; 1986 Jan; 116(1):149-56. PubMed ID: 3080557
[TBL] [Abstract][Full Text] [Related]
6. Effects of acute metabolic acidosis and alkalosis on leucine metabolism in conscious dogs.
Rodriguez NR; Miles JM; Schwenk WF; Haymond MW
Diabetes; 1989 Jul; 38(7):847-53. PubMed ID: 2544471
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effects of recombinant human insulin-like growth factor-I and insulin on glucose and leucine kinetics in humans.
Laager R; Ninnis R; Keller U
J Clin Invest; 1993 Oct; 92(4):1903-9. PubMed ID: 8408642
[TBL] [Abstract][Full Text] [Related]
8. Effects of different lipid substrates on glucose metabolism in normal postabsorptive humans.
Broussolle C; Beylot M; Chassard D; Beaufrère B
Metabolism; 1992 Dec; 41(12):1276-83. PubMed ID: 1461133
[TBL] [Abstract][Full Text] [Related]
9. Failure of infused beta-hydroxybutyrate to decrease proteolysis in man.
Miles JM; Nissen SL; Rizza RA; Gerich JE; Haymond MW
Diabetes; 1983 Mar; 32(3):197-205. PubMed ID: 6298041
[TBL] [Abstract][Full Text] [Related]
10. Beta-adrenergic blockade alters whole-body leucine metabolism in humans.
Lamont LS; Patel DG; Kalhan SC
J Appl Physiol (1985); 1989 Jul; 67(1):221-5. PubMed ID: 2759945
[TBL] [Abstract][Full Text] [Related]
11. Increase in anterior tibialis muscle protein synthesis in healthy man during mixed amino acid infusion: studies of incorporation of [1-13C]leucine.
Bennet WM; Connacher AA; Scrimgeour CM; Smith K; Rennie MJ
Clin Sci (Lond); 1989 Apr; 76(4):447-54. PubMed ID: 2714054
[TBL] [Abstract][Full Text] [Related]
12. Effect of 3-hydroxybutyrate on posttraumatic metabolism in man.
Hiraide A; Katayama M; Sugimoto H; Yoshioka T; Sugimoto T
Surgery; 1991 Feb; 109(2):176-81. PubMed ID: 1992551
[TBL] [Abstract][Full Text] [Related]
13. Elevation of plasma epinephrine concentrations inhibits proteolysis and leucine oxidation in man via beta-adrenergic mechanisms.
Kraenzlin ME; Keller U; Keller A; Thélin A; Arnaud MJ; Stauffacher W
J Clin Invest; 1989 Aug; 84(2):388-93. PubMed ID: 2569473
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor (PAF)-induced decreases in whole-body and skeletal muscle protein synthesis.
Karlstad MD; Buripakdi D; Carroll RC
Shock; 2000 Oct; 14(4):490-8. PubMed ID: 11049115
[TBL] [Abstract][Full Text] [Related]
15. Metabolic effects of a D-beta-hydroxybutyrate infusion in septic patients: inhibition of lipolysis and glucose production but not leucine oxidation.
Beylot M; Chassard D; Chambrier C; Guiraud M; Odeon M; Beaufrère B; Bouletreau P
Crit Care Med; 1994 Jul; 22(7):1091-8. PubMed ID: 8026196
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of muscle wasting in myotonic dystrophy.
Griggs RC; Jozefowicz R; Kingston W; Nair KS; Herr BE; Halliday D
Ann Neurol; 1990 May; 27(5):505-12. PubMed ID: 2360792
[TBL] [Abstract][Full Text] [Related]
17. Increased proteolysis. An effect of increases in plasma cortisol within the physiologic range.
Simmons PS; Miles JM; Gerich JE; Haymond MW
J Clin Invest; 1984 Feb; 73(2):412-20. PubMed ID: 6365973
[TBL] [Abstract][Full Text] [Related]
18. RU 486 prevents the acute effects of cortisol on glucose and leucine metabolism.
Garrel DR; Moussali R; De Oliveira A; Lesiège D; Larivière F
J Clin Endocrinol Metab; 1995 Feb; 80(2):379-85. PubMed ID: 7888013
[TBL] [Abstract][Full Text] [Related]
19. Effect of leucine on amino acid and glucose metabolism in humans.
Nair KS; Matthews DE; Welle SL; Braiman T
Metabolism; 1992 Jun; 41(6):643-8. PubMed ID: 1640850
[TBL] [Abstract][Full Text] [Related]
20. Glomerular filtration rate is increased in man by the infusion of both D,L-3-hydroxybutyric acid and sodium D,L-3-hydroxybutyrate.
Fioretto P; Trevisan R; Velussi M; Cernigoi A; De Riva C; Bressan M; Doria A; Pauletto N; Angeli P; De Donà C
J Clin Endocrinol Metab; 1987 Aug; 65(2):331-8. PubMed ID: 3298305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
